1. Home
  2. IFRX vs UPLD Comparison

IFRX vs UPLD Comparison

Compare IFRX & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IFRX
  • UPLD
  • Stock Information
  • Founded
  • IFRX 2007
  • UPLD 2010
  • Country
  • IFRX Germany
  • UPLD United States
  • Employees
  • IFRX N/A
  • UPLD N/A
  • Industry
  • IFRX Biotechnology: Pharmaceutical Preparations
  • UPLD Computer Software: Prepackaged Software
  • Sector
  • IFRX Health Care
  • UPLD Technology
  • Exchange
  • IFRX Nasdaq
  • UPLD Nasdaq
  • Market Cap
  • IFRX 117.8M
  • UPLD 115.3M
  • IPO Year
  • IFRX 2017
  • UPLD 2014
  • Fundamental
  • Price
  • IFRX $1.83
  • UPLD $4.09
  • Analyst Decision
  • IFRX Strong Buy
  • UPLD Hold
  • Analyst Count
  • IFRX 1
  • UPLD 3
  • Target Price
  • IFRX $8.00
  • UPLD $3.75
  • AVG Volume (30 Days)
  • IFRX 498.3K
  • UPLD 175.2K
  • Earning Date
  • IFRX 03-20-2025
  • UPLD 03-04-2025
  • Dividend Yield
  • IFRX N/A
  • UPLD N/A
  • EPS Growth
  • IFRX N/A
  • UPLD N/A
  • EPS
  • IFRX N/A
  • UPLD N/A
  • Revenue
  • IFRX $187,930.00
  • UPLD $278,945,000.00
  • Revenue This Year
  • IFRX $396.02
  • UPLD N/A
  • Revenue Next Year
  • IFRX $155.22
  • UPLD N/A
  • P/E Ratio
  • IFRX N/A
  • UPLD N/A
  • Revenue Growth
  • IFRX 177.12
  • UPLD N/A
  • 52 Week Low
  • IFRX $1.17
  • UPLD $1.79
  • 52 Week High
  • IFRX $2.82
  • UPLD $5.64
  • Technical
  • Relative Strength Index (RSI)
  • IFRX 32.97
  • UPLD 46.14
  • Support Level
  • IFRX $1.76
  • UPLD $4.14
  • Resistance Level
  • IFRX $1.98
  • UPLD $4.79
  • Average True Range (ATR)
  • IFRX 0.19
  • UPLD 0.27
  • MACD
  • IFRX -0.08
  • UPLD 0.02
  • Stochastic Oscillator
  • IFRX 6.65
  • UPLD 33.33

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About UPLD Upland Software Inc.

Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.

Share on Social Networks: